Spiradoline, a kappa opioid receptor agonist, produces tonic- and use-dependent block of sodium channels expressed in Xenopus oocytes
- PMID: 11483291
- DOI: 10.1016/s0306-3623(01)00079-9
Spiradoline, a kappa opioid receptor agonist, produces tonic- and use-dependent block of sodium channels expressed in Xenopus oocytes
Abstract
Spiradoline, an arylacetamide kappa (kappa) opioid receptor agonist, produced a potent tonic block of rat neuronal (EC(50)= 34+/-5 microM) and heart (EC(50)= 183+/-13 microM) sodium channels and also blocked IFMQ3 mutant neuronal sodium channels (EC(50)= 130+/-34 microM) that lack fast inactivation when expressed in Xenopus oocytes. Spiradoline produced a hyperpolarizing shift in the voltage-dependence of sodium channel inactivation and exhibited a marked frequency-dependent component to blockade of sodium channels. The onset of open channel block of the IFMQ3 channel by spiradoline was best fit with a first-order blocking scheme, yielding an affinity constant of 116 +/- 33 microM. Thus, spiradoline blocks sodium channels by interacting with the major states of the channel which could result in local anesthetic action in nerves and antiarrhythmic action in the heart.
Similar articles
-
A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist.CNS Drug Rev. 2003 Summer;9(2):187-98. doi: 10.1111/j.1527-3458.2003.tb00248.x. CNS Drug Rev. 2003. PMID: 12847558 Free PMC article. Review.
-
Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat.J Cardiovasc Pharmacol. 1998 Dec;32(6):863-74. doi: 10.1097/00005344-199812000-00002. J Cardiovasc Pharmacol. 1998. PMID: 9869491
-
Molecular analysis of the Na+ channel blocking actions of the novel class I anti-arrhythmic agent RSD 921.Br J Pharmacol. 1999 May;127(1):9-18. doi: 10.1038/sj.bjp.0702488. Br J Pharmacol. 1999. PMID: 10369450 Free PMC article.
-
U-50,488H, a kappa opioid receptor agonist, is a more potent blocker of cardiac sodium channels than lidocaine.Proc West Pharmacol Soc. 2000;43:47-50. Proc West Pharmacol Soc. 2000. PMID: 11056955 No abstract available.
-
Effects of bisaramil, a novel class I antiarrhythmic agent, on heart, skeletal muscle and brain Na+ channels.Eur J Pharmacol. 1998 Jan 19;342(1):93-104. doi: 10.1016/s0014-2999(97)01420-9. Eur J Pharmacol. 1998. PMID: 9544797
Cited by
-
Prediction of putative small molecules for manipulation of enriched signalling pathways in hESC-derived early cardiovascular progenitors by bioinformatics analysis.IET Syst Biol. 2019 Apr;13(2):77-83. doi: 10.1049/iet-syb.2018.5037. IET Syst Biol. 2019. PMID: 33444476 Free PMC article.
-
Insight into the Mode of Action of Haedoxan A from Phryma leptostachya.Toxins (Basel). 2016 Feb 22;8(2):53. doi: 10.3390/toxins8020053. Toxins (Basel). 2016. PMID: 26907348 Free PMC article.
-
A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist.CNS Drug Rev. 2003 Summer;9(2):187-98. doi: 10.1111/j.1527-3458.2003.tb00248.x. CNS Drug Rev. 2003. PMID: 12847558 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources